|
|
Post by tchalaa on May 8, 2017 14:01:05 GMT -5
MannKind Corp. (NASDAQ: MNKD) saw its shares make a massive gain on Monday after it was announced that its One Drop|Chrome is now available on Amazon Prime. Overall this is huge because the diabetes testing system is now being listed on perhaps the world’s largest online marketplace. Last week MannKind announced a collaboration with One Drop to extend One Drop’s subscription service and digital health platform, by adding Afrezza as a rapid-acting insulin offering. One Drop is a diabetes management platform that harnesses the power of mobile computing and data science to empower people with diabetes to improve their health and lives. Through Amazon Prime, One Drop can now be ordered and delivered directly to the user’s doorstep in two days or less, creating an on-demand healthcare experience for a chronic condition that requires constant management. According to industry data, more than 66 million consumers in the U.S. have Amazon Prime memberships. Source: onedrop.today/blog/2017/05/02/one-drop-on-amazon-prime/ |
|
|
|
Post by frenz on May 8, 2017 14:34:29 GMT -5
MannKind Corp. (NASDAQ: MNKD) saw its shares make a massive gain on Monday after it was announced that its One Drop|Chrome is now available on Amazon Prime. Overall this is huge because the diabetes testing system is now being listed on perhaps the world’s largest online marketplace. Last week MannKind announced a collaboration with One Drop to extend One Drop’s subscription service and digital health platform, by adding Afrezza as a rapid-acting insulin offering. One Drop is a diabetes management platform that harnesses the power of mobile computing and data science to empower people with diabetes to improve their health and lives. Through Amazon Prime, One Drop can now be ordered and delivered directly to the user’s doorstep in two days or less, creating an on-demand healthcare experience for a chronic condition that requires constant management. According to industry data, more than 66 million consumers in the U.S. have Amazon Prime memberships. Source: onedrop.today/blog/2017/05/02/one-drop-on-amazon-prime/What does it mean to be an offering? Advertising in their app basically? Or are they going to sell it too? |
|
|
|
Post by chuck on May 8, 2017 14:40:33 GMT -5
Looks like a pre-earnings pump and dump initiative is well underway. One more day of fun ahead tomorrow and then signs of weakness on wednesday early afternoon as trades are unwound. This artificial bid to disappear following earnings and then back to reality.
|
|
|
|
Post by scanderson1961 on May 8, 2017 14:54:36 GMT -5
Are you saying amazon's 66 million prime subscribers are diabetics and they are going to get same day delivery of Afrezza and one drop? May be Jeff Bozos is buying Mannkind shares today on that news.
Thinking of buying some myself. Am I late?
|
|
|
|
Post by brotherm1 on May 8, 2017 15:01:18 GMT -5
I don't know if you're late but I would say you're a little slow for sure
|
|
|
|
Post by prayingformannkind on May 8, 2017 15:42:17 GMT -5
This was a recent review on Amazon:
5.0 out of 5 starsOne Drop works great
ByClaggero
Easy to use. Accurate. I like the all-you-can-use strips. Bluetooth connects and works seemlessly. The case could be better designed. Also, I feel good to use what seems to be the defacto standard Glucose Monitor of the future. Better than Dexcom and the others. And the cool thing is that it works very well with my Afrezza inhalable insulin, which has been driving my A1C down very nicely and it's a whole lot more convenient and nicer to use than needles.
|
|
|
|
Post by sportsrancho on May 8, 2017 15:53:19 GMT -5
This was a recent review on Amazon: 5.0 out of 5 starsOne Drop works great ByClaggero Easy to use. Accurate. I like the all-you-can-use strips. Bluetooth connects and works seemlessly. The case could be better designed. Also, I feel good to use what seems to be the defacto standard Glucose Monitor of the future. Better than Dexcom and the others. And the cool thing is that it works very well with my Afrezza inhalable insulin, which has been driving my A1C down very nicely and it's a whole lot more convenient and nicer to use than needles. Awesome! Best post of the day! Thank you:-)) |
|
|
|
Post by madog365 on May 8, 2017 15:56:09 GMT -5
|
|
|
|
Post by cjm18 on May 8, 2017 15:59:24 GMT -5
That amazon review screams fake.
|
|
|
|
Post by prayingformannkind on May 8, 2017 16:00:23 GMT -5
and after that review on Amazon somebody asked about Afrezza!! I answered it and hoping a lot of others will see it as well!
|
|
|
|
Post by prayingformannkind on May 8, 2017 16:01:43 GMT -5
That amazon review screams fake. simple enough for you to go onto Amazon site and see it for yourself! |
|
|
|
Post by prayingformannkind on May 8, 2017 16:02:15 GMT -5
This was a recent review on Amazon: 5.0 out of 5 starsOne Drop works great ByClaggero Easy to use. Accurate. I like the all-you-can-use strips. Bluetooth connects and works seemlessly. The case could be better designed. Also, I feel good to use what seems to be the defacto standard Glucose Monitor of the future. Better than Dexcom and the others. And the cool thing is that it works very well with my Afrezza inhalable insulin, which has been driving my A1C down very nicely and it's a whole lot more convenient and nicer to use than needles. Awesome! Best post of the day! Thank you:-)) and after that review on Amazon somebody asked about Afrezza!! I answered it and hoping a lot of others will see it as well! |
|
|
|
Post by ssiegel on May 8, 2017 16:02:58 GMT -5
The curious thing is that it says, "Price: $76.36 FREE Shipping for Prime members once available." Usually, Amazon says when you can expect shipment of an item. So does that mean the device isn't yet available?
|
|
|
|
Post by cjm18 on May 8, 2017 16:14:42 GMT -5
That amazon review screams fake. simple enough for you to go onto Amazon site and see it for yourself! There are fake reviews on amazon. Someone obviously wanted to promote afrezza. How can finger pricks be better than dexcom. |
|
|
|
Post by buyitonsale on May 8, 2017 16:18:30 GMT -5
I believe that One Drop will offer a monthly / yearly subscription service add on for Afrezza patients. Mannkind will probably subsidize it (since they have the product) and it will be shipped directly to patients "Uber for Diabetes" style. It would be a smart move as only about 20K patients are needed to be profitable. Even if Mannkind does not make any money on the subscription it will finally get the patient base it needs to succeed. One Drop has the user base and exposure that Mannkind needs. www.healthline.com/diabetesmine/afrezza-updates-february-2017#7 |
|
